MADURAMICIN
SMILES | CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC |
InChIKey | RWVUEZAROXKXRT-VQLSFVLHSA-N |
Chemical properties
Hydrogen bond acceptors | 16 |
Hydrogen bond donors | 4 |
Rotatable bonds | 13 |
Molecular weight (Da) | 916.5 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | No |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT1B | 5HT1B | Rat | 5-Hydroxytryptamine | A | pKi | 8.87 | 8.87 | 8.87 | ChEMBL |
α1B | ADA1B | Rat | Adrenoceptors | A | pKi | 5.58 | 5.58 | 5.58 | ChEMBL |
α1A | ADA1A | Rat | Adrenoceptors | A | pKi | 5.87 | 5.87 | 5.87 | ChEMBL |
α1D | ADA1D | Human | Adrenoceptors | A | pKi | 6.26 | 6.26 | 6.26 | ChEMBL |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 7.92 | 7.92 | 7.92 | ChEMBL |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 6.63 | 6.63 | 6.63 | ChEMBL |
5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pKi | 8.35 | 8.35 | 8.35 | ChEMBL |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 7.17 | 7.17 | 7.17 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pKi | 5.84 | 5.84 | 5.84 | ChEMBL |
5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pKi | 9.1 | 9.1 | 9.1 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 7.68 | 7.68 | 7.68 | ChEMBL |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 7.75 | 7.75 | 7.75 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pKi | 8.03 | 8.03 | 8.03 | ChEMBL |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.61 | 8.61 | 8.61 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 6.63 | 6.63 | 6.63 | ChEMBL |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT1B | 5HT1B | Rat | 5-Hydroxytryptamine | A | pIC50 | 8.53 | 8.53 | 8.53 | ChEMBL |
α1B | ADA1B | Rat | Adrenoceptors | A | pIC50 | 5.33 | 5.33 | 5.33 | ChEMBL |
α1A | ADA1A | Rat | Adrenoceptors | A | pIC50 | 5.48 | 5.48 | 5.48 | ChEMBL |
α1D | ADA1D | Human | Adrenoceptors | A | pIC50 | 5.95 | 5.95 | 5.95 | ChEMBL |
α2B | ADA2B | Human | Adrenoceptors | A | pIC50 | 7.57 | 7.57 | 7.57 | ChEMBL |
α2C | ADA2C | Human | Adrenoceptors | A | pIC50 | 5.79 | 5.79 | 5.79 | ChEMBL |
5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pIC50 | 8.11 | 8.11 | 8.11 | ChEMBL |
α2A | ADA2A | Human | Adrenoceptors | A | pIC50 | 6.75 | 6.75 | 6.75 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pIC50 | 5.54 | 5.54 | 5.54 | ChEMBL |
5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pIC50 | 8.77 | 8.77 | 8.77 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pIC50 | 7.48 | 7.48 | 7.48 | ChEMBL |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pIC50 | 7.47 | 7.47 | 7.47 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pIC50 | 7.57 | 7.57 | 7.57 | ChEMBL |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pIC50 | 8.06 | 8.06 | 8.06 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pIC50 | 6.15 | 6.15 | 6.15 | ChEMBL |